ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 1077 • ACR Convergence 2025

    Health literacy and work status in people with inflammatory arthritis: a cluster analysis in a national cohort

    Mrinalini Dey1, Sam Norton2, Andrew Cope2, MAYA BUCH3, Richard Osborne4, James Galloway2 and Elena Nikiphorou2, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2King's College London, London, United Kingdom, 3UNIVERSITY OF MANCHESTER, MANCHESTER, United Kingdom, 4La Trobe University, Melbourne, Victoria, Australia

    Background/Purpose: Work status and employment can be impacted in people with inflammatory arthritis (IA). We aimed to assess the association between health literacy and work…
  • Abstract Number: 0381 • ACR Convergence 2025

    Improving Participation in The Lupus Foundation of America’s Research Accelerated by You (RAY) Patient Registry By Understanding Patient Preference in Communication Strategies

    Safoah Agyemang1, Melicent Miller1, Tori Justin2, Lydia Oberholtzer2 and Joy Buie1, 1Lupus Foundation of America, Washington, DC, 2Sharp Insight LLC, Montgomery County, MD

    Background/Purpose: The purpose of Research Accelerated by You (RAY) is to amplify awareness about clinical research and trials and ensure lupus patient partnership in therapeutic…
  • Abstract Number: 2615 • ACR Convergence 2025

    The Cost of Complexity: Financial Toxicity in Rheumatic Disease, Cancer, and Their Intersection

    Manush Sondhi1, Bhavik Bansal2, Hemant Khandelia1, Jiha Lee3, Sebastian E Sattui4, Siddharth Singh5 and Namrata Singh6, 1University of Washington, Seattle, WA, 2UT Southwestern Medical Center, Dallas, 3University of Michigan, Ann Arbor, MI, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 5University of California San Diego, San Diego, CA, 6University of Washington, Bellevue, WA

    Background/Purpose: Financial toxicity (FT) is the financial burden of accessing health care, well known in cancer and increasingly seen in rheumatic disease (RD). We compared…
  • Abstract Number: 1704 • ACR Convergence 2025

    Relationships between Neighborhood Disadvantage, Cumulative Social Disadvantage, and JIA Outcomes: A CARRA Registry Study

    William Soulsby1, John Boscardin2, Daniel Horton3, Andrea Knight4, Karine Toupin-April5 and Emily von Scheven2, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 4Hospital for Sick Children, Toronto, ON, Canada, 5University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: Social determinants of health (SDOH) operate across individual, family, and community levels. We previously demonstrated that cumulative social disadvantage, comprised of individual and family-level…
  • Abstract Number: 1076 • ACR Convergence 2025

    Racial Differences in Real-World Use of Urate-Lowering and Adjunctive Therapies for Gout: A 10-Year Propensity-Matched Cohort Study

    Michael Hamilton1, Justin Riley Lam2, Emmanuel Otabor3, Laith Alomari3, Maxim Barnett3, Arthur Lau4 and Irene Tan5, 1Jefferson Einstein Hospital, Philadelphia, Philadelphia, PA, 2Jefferson Einstein Hospital, Philadelphia, PA, 3Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 4Jefferson Einstein Hospital, Maple Glen, PA, 5Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Although achieving target serum urate (SU) and reducing cardiovascular events are cornerstones of gout management, little is known about contemporary treatment patterns across racial…
  • Abstract Number: 0368 • ACR Convergence 2025

    Factors Associated with Patient Acceptability of Rheumatology Care Delivered by Telemedicine

    Hareem Farooq1, Lesley Jackson1, Rahima Begum2, Gary Cutter2, Kenneth Saag3, Jinoos Yazdany4 and Maria I. ("Maio") Danila5, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, 3The University of Alabama at Birmingham, Birmingham, AL, 4UCSF, San Francisco, CA, 5University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: Home-based telemedicine is an efficient healthcare delivery approach. A recent randomized clinical trial (RCT) found that in-person visits may be preferred among rheumatology patients.…
  • Abstract Number: 2565 • ACR Convergence 2025

    Assessing Participation in the Lupus Sister Circle Support Group

    Khadija Dantata, Wendy Rodgers and Lety Ocana, The Lupus Foundation of America, Washington, DC

    Background/Purpose: Relative to White people with lupus (PWL), Black/African American (B/AA) PWL are three times as likely to develop lupus and suffer a severe form…
  • Abstract Number: 1689 • ACR Convergence 2025

    Addressing Perceived Discrimination in Lupus Care: Enhancing Patient Empowerment and Health Equity Through Education and Support

    Kimberly Cabrera1, Priscilla Calvache2, Lillian Mendez3, Giselle Morales4 and Jillian Rose-Smith2, 1Hospital for Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, 3Patient Advocate, Carteret, NJ, 4Hospital for Special Surgery, Glendale, NY

    Background/Purpose: SLE is a life-threatening autoimmune disease that disproportionately affects African American (AA), Hispanic/Latino, & Asian populations. These communities experience serious health disparities, including more…
  • Abstract Number: 1075 • ACR Convergence 2025

    Racial Differences in Management and Clinical Outcomes of Giant-Cell Arteritis: A Real-World Propensity-Matched Study

    Michael Hamilton1, Justin Riley Lam2, Emmanuel Otabor3, Laith Alomari3, Maxim Barnett3, Fabian Rodriguez Quinonez4 and Irene Tan5, 1Jefferson Einstein Hospital, Philadelphia, Philadelphia, PA, 2Jefferson Einstein Hospital, Philadelphia, PA, 3Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 4Einstein Medical Center Philadelphia, Philadelphia, PA, 5Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Giant-cell arteritis (GCA) is usually described in people of Northern-European ancestry, and little is known about outcomes in Black and Hispanic (B-His) patients. Using…
  • Abstract Number: 0364 • ACR Convergence 2025

    Group-Based Medical Mistrust and Logistical Factors Influencing Rheumatology Clinical Trial Enrollment: A Single-Center Cross-Sectional Survey

    Andreina Martinez Paulino1, Miles King2, Danny Arias Diaz1, Asma Cheema3 and Muznay Khawaja4, 1Jersey City Medical Center, Jersey City, NJ, 2Albert Einstein College of Medicine, New York, NY, 3Montefiore Einstein , Wakefield Campus, Woodbridge Township, NJ, 4Jersey City Medical Center, Hoboken, NJ

    Background/Purpose: Clinical trials are the cornerstone of evidence-based rheumatology, yet enrolling and retaining a representative patient cohort remains challenging. While underrepresentation of underserved minorities is…
  • Abstract Number: 2518 • ACR Convergence 2025

    Impact of psychiatric comorbidity on disease outcomes in ANCA-associated vasculitis: A multi-center retrospective cohort study

    Saloni Patel1, Brendan Denvir2, Maria Kaltchenko1, Aaron Bao3, Varsha Simha1, Michael Cammarata4 and Jun Kang5, 1Johns Hopkins University School of Medicine, Baltimore, 2Johns Hopkins, Baltimore, MD, 3Johns Hopkins School of Medicine, Baltimore, MD, 4Johns Hopkins, Phoenix, MD, 5Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic small vessel vasculitis associated with significant morbidity and complex care needs across a broad demographic…
  • Abstract Number: 1633 • ACR Convergence 2025

    Social Determinants of Health and Adverse Perinatal Outcomes in Women with Rheumatic Diseases

    Andres M. Ortiz-Rios1, Fany Rocio Arevalo-Nieto1, Braulio R. Avalos-Garcia1, Mara Alejandra Ponce-Santillan1, Maria Eugenia Corral-Trujillo2, Tania Sarahi Ayala-Garcia1, Dunja Athalia Perez-Garfias1, David Alejandro Ramirez-Cantu1, Leonardo Uriel Tapia-Aguayo1, Jesus Mario Ortiz-Palafox3, Eva Abigaid Galindo-Calvillo1, Emmanuel Dominguez-Chapa4, Lorena Perez-Barbosa1, Dionicio A. Galarza-Delgado5 and Cassandra Michele Skinner-Taylor1, 1Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterey, Nuevo Leon, Mexico, 4Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 5Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Social determinants of health (SDH) are the conditions in which individuals are born, grow, live and work. These factors (education, socioeconomic status, access to…
  • Abstract Number: 1074 • ACR Convergence 2025

    Racial Disparities in Cardiovascular, Ocular, and Treatment Outcomes in US Patients with Behçet’s Disease: A Propensity-Matched Real-World Analysis

    Michael Hamilton1, Justin Riley Lam2, Emmanuel Otabor3, Laith Alomari3, Maxim Barnett3, Shahrzad Abdollahi2 and Irene Tan4, 1Jefferson Einstein Hospital, Philadelphia, Philadelphia, PA, 2Jefferson Einstein Hospital, Philadelphia, PA, 3Jefferson Einstein Hospital Philadelphia, Philadelphia, PA, 4Einstein Healthcare Network Philadelphia - Jefferson Health, Bala Cynwyd, PA

    Background/Purpose: Racial/ethnic disparities in Behçet’s disease (BD) outcomes are largely undocumented in the United States. Given known differences in disease expression across populations globally, we…
  • Abstract Number: 0326 • ACR Convergence 2025

    Gender Disparities in Clinical Outcomes Among Older Adults with Knee Osteoarthritis: A Retrospective Cohort Study

    Kinga Grzybowski1, Ahmer Khan2, Samuel Bonomo3 and Arthur Lau4, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Montgomery Hospital, East Norriton, PA, 4Jefferson Einstein Hospital, Maple Glen, PA

    Background/Purpose: Osteoarthritis (OA) is the most common type of arthritis which classically affects multiple joints, mainly the knees. About 595 million people worldwide suffer from…
  • Abstract Number: 2199 • ACR Convergence 2025

    Disparities in Reproductive Health Counseling Among Hispanic Women with Autoimmune Rheumatic Diseases: Insights from a Patient-Reported Survey in an Urban Safety-Net Setting

    Eaman Alhassan1, Laura Kobashigawa2, Vanessa Ramos2, Jack Rodman2 and Leanna Wise3, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Southern California, Los Angeles, 3LAGMC/Keck Medicine of USC, Los Angeles

    Background/Purpose: Reproductive-age Hispanic women with rheumatoid arthritis, juvenile idiopathic arthritis (combined, inflammatory arthritis; IA), and systemic lupus erythematosus (SLE) often bear a higher disease burden…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology